La bourse est fermée
  • CAC 40

    4 594,24
    +24,57 (+0,54 %)
     
  • Euro Stoxx 50

    2 958,21
    -1,82 (-0,06 %)
     
  • Dow Jones

    26 501,60
    -157,51 (-0,59 %)
     
  • EUR/USD

    1,1650
    -0,0029 (-0,24 %)
     
  • Gold future

    1 878,80
    +10,80 (+0,58 %)
     
  • BTC-EUR

    11 614,38
    +21,33 (+0,18 %)
     
  • CMC Crypto 200

    265,42
    +1,78 (+0,68 %)
     
  • Pétrole WTI

    35,72
    -0,45 (-1,24 %)
     
  • DAX

    11 556,48
    -41,59 (-0,36 %)
     
  • FTSE 100

    5 577,27
    -4,48 (-0,08 %)
     
  • Nasdaq

    10 911,59
    -274,00 (-2,45 %)
     
  • S&P 500

    3 269,96
    -40,15 (-1,21 %)
     
  • Nikkei 225

    22 977,13
    -354,81 (-1,52 %)
     
  • HANG SENG

    24 107,42
    -479,18 (-1,95 %)
     
  • GBP/USD

    1,2951
    +0,0028 (+0,22 %)
     

Immunosuppressant Drugs Market Research Report by Function, by Route of Administration, by Drug Class, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5 min de lecture

Immunosuppressant Drugs Market Research Report by Function (Autoimmune Diseases and Organ Transplant), by Route of Administration (Intravenous and Oral), by Drug Class, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Immunosuppressant Drugs Market Research Report by Function, by Route of Administration, by Drug Class, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05940958/?utm_source=GNW

The Global Immunosuppressant Drugs Market is expected to grow from USD 893.46 Million in 2019 to USD 1,213.81 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.23%.

Market Segmentation & Coverage:
This research report categorizes the Immunosuppressant Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Function, the Immunosuppressant Drugs Market studied across Autoimmune Diseases and Organ Transplant. The Autoimmune Diseases further studied across Localized Autoimmune Disease and Systemic Autoimmune Disease.

"The Intravenous is projected to witness the highest growth during the forecast period"

Based on Route of Administration, the Immunosuppressant Drugs Market studied across Intravenous and Oral. The Oral commanded the largest size in the Immunosuppressant Drugs Market in 2019. On the other hand, the Intravenous is expected to grow at the fastest CAGR during the forecast period.

"The Calcineurin Inhibitor is projected to witness the highest growth during the forecast period"

Based on Drug Class, the Immunosuppressant Drugs Market studied across Antiproliferative Agent, Calcineurin Inhibitor, Steroid, and mTOR Inhibitor. The Calcineurin Inhibitor commanded the largest size in the Immunosuppressant Drugs Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.

"The Organ Transplant Center is projected to witness the highest growth during the forecast period"

Based on End User, the Immunosuppressant Drugs Market studied across Clinic, Hospital, Organ Transplant Center, Old Age Home, and Rehabilitation Center. The Hospital commanded the largest size in the Immunosuppressant Drugs Market in 2019. On the other hand, the Organ Transplant Center is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Immunosuppressant Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Immunosuppressant Drugs Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Immunosuppressant Drugs Market including Accord Healthcare Ltd., Actavis, Inc., Allergan PLC, Astellas Pharma, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals, Inc., Mylan Laboratories, Inc., Novartis AG, Pfizer Inc., Sanofi, and Zydus Cadila.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Immunosuppressant Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Immunosuppressant Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunosuppressant Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunosuppressant Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Immunosuppressant Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Immunosuppressant Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Immunosuppressant Drugs Market?
Read the full report: https://www.reportlinker.com/p05940958/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001